Broadfin Capital Lowered By $3.83 Million Its Antares Pharma (ATRS) Position; Eca Marcellus Trust I (ECT) Sentiment Is 0.7

Broadfin Capital Llc decreased Antares Pharma Inc (ATRS) stake by 12.86% reported in 2016Q4 SEC filing. Broadfin Capital Llc sold 1.91 million shares as Antares Pharma Inc (ATRS)’s stock rose 32.39%. The Broadfin Capital Llc holds 12.97M shares with $30.22 million value, down from 14.89M last quarter. Antares Pharma Inc now has $405.67 million valuation. The stock decreased 2.87% or $0.08 on May 10, reaching $2.71. About 1.70M shares traded or 6.92% up from the average. Antares Pharma Inc (NASDAQ:ATRS) has risen 58.52% since October 3, 2016 and is uptrending. It has outperformed by 47.62% the S&P500.

ECA Marcellus Trust I is a statutory trust. The company has market cap of $41.41 million. The Trust is formed by Energy Corporation of America (ECA) to own royalty interests in natural gas properties owned and operated by ECA in the Marcellus Shale formation in Greene County, Pennsylvania. It has a 11.39 P/E ratio. The Trust does not conduct any activities or activities.

Ratings analysis reveals 0 of Eca Marcellus Trust I’s analysts are positive. Out of 2 Wall Street analysts rating Eca Marcellus Trust I, 0 give it “Buy”, 2 “Sell” rating, while 0 recommend “Hold”. ECT was included in 3 notes of analysts from August 28, 2015. As per Tuesday, September 1, the company rating was downgraded by Raymond James. The firm has “Sell” rating given on Tuesday, September 8 by Zacks. The firm earned “Sell” rating on Friday, August 28 by Zacks.

The stock decreased 2.17% or $0.05 on May 10, reaching $2.25. About 83,493 shares traded or 135.97% up from the average. Eca Marcellus Trust I (NYSE:ECT) has risen 8.49% since October 3, 2016 and is uptrending. It has underperformed by 2.42% the S&P500.

United Bank Inc. holds 0.06% of its portfolio in Eca Marcellus Trust I for 67,725 shares. Amg National Trust Bank owns 34,421 shares or 0.01% of their US portfolio. Moreover, American Research & Management Co. has 0% invested in the company for 1,200 shares. The California-based California Public Employees Retirement System has invested 0% in the stock. Citadel Advisors Llc, a Illinois-based fund reported 16,005 shares.

Broadfin Capital Llc increased Endo Intl Plc (NASDAQ:ENDP) stake by 105,500 shares to 1.56 million valued at $25.69M in 2016Q4. It also upped Recro Pharma Inc (NASDAQ:REPH) stake by 650,000 shares and now owns 3.10M shares. Idera Pharmaceuticals Inc (NASDAQ:IDRA) was raised too.